These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2145908)

  • 1. Disposition, pharmacokinetics, and metabolism of 14C-fotemustine in cancer patients.
    Ings RM; Gray AJ; Taylor AR; Gordon BH; Breen M; Hiley M; Brownsill R; Marchant N; Richards R; Wallace D
    Eur J Cancer; 1990; 26(7):838-42. PubMed ID: 2145908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomas.
    Tranchand B; Lucas C; Biron P; Giroux B; Gordon B; Richards R; Solere P; Roux N; Evene E; Mornex F
    Cancer Chemother Pharmacol; 1993; 32(1):46-52. PubMed ID: 8462123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative disposition of [14C]-fotemustine in non-tumourous and tumourous mice.
    Ings RM; Breen M; Devereux K; Gray AJ; Edwards FE; Lucas C; Briggs M; Robinson BV; Campbell DB
    Cancer Chemother Pharmacol; 1990; 27(2):106-10. PubMed ID: 2249325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method for the measurement of nitrosoureas in plasma: an h.p.l.c. procedure for the measurement of fotemustine kinetics.
    Gordon BH; Richards RP; Hiley MP; Gray AJ; Ings RM; Campbell DB
    Xenobiotica; 1989 Mar; 19(3):329-39. PubMed ID: 2665327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric study.
    Iliadis A; Launay-Iliadis MC; Lucas C; Fety R; Lokiec F; Tranchand B; Milano G
    Eur J Cancer; 1996 Mar; 32A(3):455-60. PubMed ID: 8814692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and glutathione conjugation-related degradation of fotemustine: formation and characterization of a glutathione conjugate of diethyl (1-isocyanatoethyl)phosphonate, a reactive metabolite of fotemustine.
    Brakenhoff JP; Commandeur JN; de Kanter FJ; van Baar BL; Luijten WC; Vermeulen NP
    Chem Res Toxicol; 1994; 7(3):380-9. PubMed ID: 8075370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic intra-arterial infusion of fotemustine: pharmacokinetics.
    Fety R; Lucas C; Solere P; Cour V; Vignoud J
    Cancer Chemother Pharmacol; 1992; 31(2):118-22. PubMed ID: 1451232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition and metabolism in 1-(2-chloroethyl)-3-(2',3',4'-tri-o-acetyl, ribopyranosyl)-1-nitrosourea in rats.
    Godeneche D; Moreau MF; Madelmont JC; Duprat J; Plagne R
    Cancer Res; 1982 Feb; 42(2):525-9. PubMed ID: 6799188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of fotemustine and BCNU in plasma, liver and tumor tissue of rats bearing two lines of Walker 256 carcinoma.
    Guaitani A; Corada M; Lucas C; Lemoine A; Garattini S; Bartosek I
    Cancer Chemother Pharmacol; 1991; 28(4):293-7. PubMed ID: 1879046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the clinical pharmacokinetics of fotemustine in various tumor indications].
    Lokiec F; Beerblock K; Deloffre P; Lucas C; Bizzari JP
    Bull Cancer; 1989; 76(10):1063-9. PubMed ID: 2635634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological disposition of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in mice.
    Rahman A; Luc PV; Schein PS; Woolley PV
    Cancer Res; 1984 Jan; 44(1):149-53. PubMed ID: 6690033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic profile of fotemustine in rat plasma by electrochemical detection.
    Bartosek I; Corada M; Dallarda S; Lucas C; Deloffre P; Guaitani A
    Xenobiotica; 1991 Feb; 21(2):235-42. PubMed ID: 2058178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interspecies comparison of pharmacokinetic parameters of fotemustine (nitrosourea S 10036): mice, rats, monkeys, dogs and man].
    Lucas C; Ings B; Gray AJ; Deloffre P; Lokiec F; Campbell B; Beerblock K
    Bull Cancer; 1989; 76(8):863-5. PubMed ID: 2515897
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent.
    Tatsuta N; Suzuki N; Mochizuki T; Koya K; Kawakami M; Shishido T; Motoji N; Kuroiwa H; Shigematsu A; Chen LB
    Cancer Chemother Pharmacol; 1999; 43(4):295-301. PubMed ID: 10071980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.
    Marzolini C; Decosterd LA; Shen F; Gander M; Leyvraz S; Bauer J; Buclin T; Biollaz J; Lejeune F
    Cancer Chemother Pharmacol; 1998; 42(6):433-40. PubMed ID: 9788568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumors.
    Kreis W; Budman DR; Vinciguerra V; Hock K; Baer J; Ingram R; Schacter LP; Fields SZ
    Cancer Chemother Pharmacol; 1996; 38(4):378-84. PubMed ID: 8674162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and metabolism of the antitumor agent pyrazine-2-diazohydroxide in mouse and beagle dog.
    Moore DJ; Brodfuehrer JI; Wilke TJ; Powis G
    Cancer Chemother Pharmacol; 1988; 21(4):269-73. PubMed ID: 3370734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A probable mechanism for hyperpigmentation by fotemustine.
    Schallreuter KU; Ring J
    Dermatology; 1992; 185(1):76-7. PubMed ID: 1638080
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.
    Cundy KC; Bidgood AM; Lynch G; Shaw JP; Griffin L; Lee WA
    Drug Metab Dispos; 1996 Jul; 24(7):745-52. PubMed ID: 8818571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability of two nitrosoureas, carmustine and fotemustine in rat cortex.
    Meulemans A; Giroux B; Hannoun P; Henzel D; Bizzari JP; Mohler J
    Chemotherapy; 1989; 35(5):313-9. PubMed ID: 2791708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.